Patent Assignment
Reel/Frame 043341/0557
Change of Name
Recorded: 2017-07-26
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Peptide Nucleic Acid Conjugates
Patent:
7,223,833 →
Application:
08/319,411 →
Antisense Modulation of Apolipoprotein (a) Expression
Antisense Modulation of Bcl-X Expression
Chloral-Free Dca in Oligonucleotide Synthesis
Methods for Detection of Chloral Hydrate in Dichloroacetic Acid
Oligonucleotides Having Site Specific Chiral Phosphorothioate Internucleoside Linkages
Patent:
39,464 →
Application:
10/925,348 →
Process for the Synthesis of Oligomeric Compounds
Supports for Oligomer Synthesis
Process for the Synthesis of Oligomeric Compounds
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0349 →
Release of Security Interest
Jan 24, 2011
From: DRI CAPITAL INC.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 025685/0658 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →